Molson Coors Canada Inc.
Molson Coors Canada Inc. (MXGBF) Financial Performance & Income Statement Overview
Explore the financials of Molson Coors Canada Inc. (MXGBF), including yearly and quarterly data on income, cash flow, and balance sheets.
Molson Coors Canada Inc. (MXGBF) Income Statement & Financial Overview
Explore comprehensive income reports for Molson Coors Canada Inc. MXGBF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.30B | $2.74B | $3.04B | $3.25B |
| Cost of Revenue | $1.45B | $1.70B | $1.84B | $1.92B |
| Gross Profit | $850.90M | $1.04B | $1.20B | $1.33B |
| Gross Profit Ratio | $0.37 | $0.38 | $0.40 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $653.20M | $649.70M | $684.70M | $728.50M |
| Operating Expenses | $664.60M | $649.40M | $751.30M | $730.30M |
| Total Costs & Expenses | $2.12B | $2.35B | $2.59B | $2.64B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $180.30M | $247.30M | $175.40M | $167.70M |
| EBITDA | $378.00M | $604.90M | $693.20M | $776.40M |
| EBITDA Ratio | $0.16 | $0.22 | $0.23 | $0.24 |
| Operating Income | $186.30M | $388.10M | $451.20M | $608.80M |
| Operating Income Ratio | $0.08 | $0.14 | $0.15 | $0.19 |
| Other Income/Expenses (Net) | -$30.00M | -$41.80M | -$119.80M | -$39.70M |
| Income Before Tax | $156.30M | $346.30M | $331.40M | $559.90M |
| Income Before Tax Ratio | $0.07 | $0.13 | $0.11 | $0.17 |
| Income Tax Expense | $33.20M | $52.60M | $102.60M | $134.60M |
| Net Income | $121.00M | $287.80M | $199.80M | $427.00M |
| Net Income Ratio | $0.05 | $0.11 | $0.07 | $0.13 |
| EPS | $0.60 | $1.37 | $0.95 | $2.03 |
| Diluted EPS | $0.59 | $1.37 | $0.95 | $2.03 |
| Weighted Avg Shares Outstanding | $203.00M | $210.34M | $210.34M | $210.34M |
| Weighted Avg Shares Outstanding (Diluted) | $204.00M | $210.80M | $210.80M | $210.80M |
The company's financials show resilient growth, with revenue advancing from $3.25B in Q2 2024 to $2.30B in Q1 2025. Gross profit remained healthy with margins at 37% in Q1 2025 compared to 41% in Q2 2024. Operating income hit $186.30M last quarter, sustaining a consistent 8% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $378.00M. Net income dropped to $121.00M, while earnings per share reached $0.60. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan